(Q66921991)
Statements
Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275) (English)
Douglass HO Jr
H. O. Douglass
P. T. Lavin
J. T. Evans
A. Mittelman
1 August 1979